Investigating FDA-approved drugs in an animal model of KCNT1-childhood epilepsy to identify potential new therapies for treating children

Investigating FDA-approved drugs in an animal model of KCNT1-childhood epilepsy to identify potential new therapies for treating children

Chief Investigator: Professor Leanne Dibbens Funding Amount: $ 100,000 Recipient: University of South Australia Overview: KCNT1 mutations cause one of the most severe forms of epilepsy in children, resulting in
Psychotropic medications in children and adolescents: investigating longitudinal trends and determinants of use, persistence, and outcomes

Psychotropic medications in children and adolescents: investigating longitudinal trends and determinants of use, persistence, and outcomes

Chief Investigator: Associate Professor Luke Grzeskowiak Funding Amount: $99,983 Recipient: Flinders University Overview: Considerable debate surrounds the widespread prescribing of psychotropic medications in young people. While these medications have the potential to help
Out-of-home care is not one thing: effects of complex care patterns on health, development and welfare outcomes

Out-of-home care is not one thing: effects of complex care patterns on health, development and welfare outcomes

Chief Investigator: Dr Dandara Haag Funding Amount: $99,789 Recipient: The University of Adelaide Overview: Out-of-home care (OOHC) experiences have significant implications on life outcomes. Early entry, while associated with longer-term stability, can lead
Human umbilical cord-derived haemangioblasts: discovery of a robust stem cell population for skin wound healing in children

Human umbilical cord-derived haemangioblasts: discovery of a robust stem cell population for skin wound healing in children

Chief Investigator: Dr Mohammadhossein Hassanshahi [Early Career Researcher] Funding Amount: $39,800 Recipient: The University of Adelaide Overview: Paediatric patients generally have much more vulnerable skin, and are more likely to have acute trauma